維持性血液透析患者心血管疾病患病情況及危險(xiǎn)因素分析
[Abstract]:Objective to investigate the prevalence and risk factors of cardiovascular disease (CVD) in patients with maintenance hemodialysis (MHD). Methods from October 2013 to October 2014, 472 patients with end-stage kidney disease who were treated by hemodialysis in blood purification center of 7 tertiary hospitals in Zhengzhou were selected. Collect general information of all patients and relevant laboratory results. Patients were divided into CVD group and no CVD group according to whether cardiovascular events occurred. T test and 蠂 2 test were used to compare the difference of the above indexes between the two groups. Then the risk factors of cardiovascular disease in hemodialysis patients were analyzed by Logistic regression analysis. Results in 472 patients with MHD, the mean age was 55.60 鹵11.93 years, male 243, female 229, mean dialysis age 39.30 鹵21.85 months. The incidence of cardiovascular events in 56.4%.CVD group was compared with that in no CVD group, age, systolic blood pressure before dialysis. Before dialysis, there were significant differences in serum creatinine (Scr), (UA), cystatin C (Cys-C), urea clearance index (Kt/V), triglyceride (TG), hypersensitive C-reactive protein (hs-CRP), serum phosphorus and type B brain natriuretic peptide (BNP) (P0.05). Hemoglobin (Hb), total protein (TP), albumin (ALB), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), serum calcium, total parathyroid hormone (iPTH), before dialysis urea nitrogen (BUN) had no significant difference. Age of hemodialysis, serum uric acid, cystatin C, triglyceride and hypersensitive C-reactive protein were risk factors of CVD in hemodialysis patients. Conclusion (1) the incidence of cardiovascular disease in MHD patients is high and should be actively prevented and treated. 2, age, dialysis age, serum uric acid, cystatin C, triglyceride and hypersensitive C-reactive protein may be independent risk factors for cardiovascular disease in MHD patients.
【學(xué)位授予單位】:鄭州大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R692.5;R54
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 王立瑞;李江濤;余晨;;維持性血液透析患者甲狀旁腺素水平與左心室肥厚關(guān)系的研究[J];臨床腎臟病雜志;2016年10期
2 安坤;;血液透析患者與持續(xù)不臥床腹膜透析患者心絞痛發(fā)生率對(duì)比分析[J];中國(guó)現(xiàn)代藥物應(yīng)用;2016年20期
3 李強(qiáng);張全;;血液透析患者甲狀旁腺激素對(duì)心臟結(jié)構(gòu)和功能的影響[J];中國(guó)醫(yī)藥指南;2016年27期
4 陳忠輝;何靜;;維持性血液透析患者血管鈣化相關(guān)因素研究[J];蚌埠醫(yī)學(xué)院學(xué)報(bào);2016年09期
5 豆利軍;王國(guó)平;閔瘤芳;張順國(guó);;維持性血液透析患者血胱抑素、NT-proBNP水平與心血管事件發(fā)生的相關(guān)性分析[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2016年26期
6 錢(qián)瑩;常安瑾;俞海瑾;陳孜瑾;馬曉波;陳曉農(nóng);陳楠;;清晨高血壓在維持性血液透析患者中的檢測(cè)及其臨床意義[J];中國(guó)血液凈化;2016年01期
7 李春明;;血清同型半胱氨酸、成纖維細(xì)胞生長(zhǎng)因子23、klotho蛋白與血液透析患者心血管功能關(guān)系研究[J];中國(guó)實(shí)驗(yàn)診斷學(xué);2015年11期
8 唐雪蓮;萬(wàn)靜芳;林利容;盧曉梅;霍本剛;何婭妮;李開(kāi)龍;;維持性血液透析患者清晨高血壓與心腦血管事件的關(guān)系[J];中國(guó)血液凈化;2015年08期
9 玄先法;王玉新;李清芹;張以勤;周麗娜;葉婧;;終末期腎病血液透析患者心血管疾病危險(xiǎn)因素分析[J];中華臨床醫(yī)師雜志(電子版);2015年13期
10 張麗潔;張愛(ài)華;朱寧;崔專;田信奎;莊震;張楓;蘇春燕;范敏華;;血液透析患者血紅蛋白變異性和與新發(fā)心腦血管事件及動(dòng)靜脈內(nèi)瘺血栓形成有關(guān)[J];中國(guó)血液凈化;2015年06期
相關(guān)碩士學(xué)位論文 前4條
1 陳源;中晚期慢性腎臟病患者礦物質(zhì)和骨異常與心臟損害之間的相關(guān)性分析[D];福建醫(yī)科大學(xué);2015年
2 沈立婷;血清胱抑素C與終末期腎病患者心腦血管并發(fā)癥的相關(guān)性研究[D];吉林大學(xué);2014年
3 鐘曉菁;維持性血液透析患者血紅蛋白變異性與心腦血管事件及死亡的相關(guān)性研究[D];復(fù)旦大學(xué);2013年
4 閆敏;維持性血液透析患者發(fā)生心血管不良事件的影響因素分析[D];山東大學(xué);2012年
,本文編號(hào):2265091
本文鏈接:http://www.sikaile.net/linchuangyixuelunwen/2265091.html